7Indexed trials
drug · Product Intelligence
Minocycline
Pipeline Intelligence
Minocycline: 7 indexed trials, 7 sponsors; 17 linked Orange Book patents and 11 FDA-linked events where matched.
7Sponsors
17Orange Book patent links
11FDA-linked events
Development evidence
NCT01073813University of Calgary · multiple_sclerosisPHASE2
NCT01433055University of Maryland, Baltimore · schizophreniaNA
NCT02456948Charite University, Berlin, Germany · depressionPHASE2
NCT03117530University of California, Los Angeles · autismPHASE1
NCT03320018Stony Brook University · strokePHASE2, PHASE3
NCT04031755Children's Hospital Medical Center, Cincinnati · autismPHASE1
NCT05958069Xijing Hospital · epilepsyNA
FDA / patent evidence
11364212EMROSI · app 2190152039-01-07
10905664EMROSI · app 2190152039-01-07
12594252EMROSI · app 2190152039-01-07
11191740EMROSI · app 2190152039-01-07
12138311ZILXI · app 2136902030-10-01
12661407ZILXI · app 2136902030-10-01
9675700ZILXI · app 2136902030-10-01
10265404ZILXI · app 2136902030-10-01
10322186ZILXI · app 2136902030-10-01
10946101ZILXI · app 2136902030-10-01
8945516ZILXI · app 2136902030-10-01
8992896ZILXI · app 2136902030-10-01
Regulatory context
FDA_EXCLUSIVITYEMROSI · NP2027-11-01
FDA_APPROVALEMROSI · 2024-11-01
FDA_APPROVALZILXI · 2020-05-28
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 2020-05-01
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 2017-11-16
FDA_APPROVALXIMINO · 2012-07-11
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 2009-08-13
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 2003-08-12
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 2001-04-18
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 1992-03-02
FDA_APPROVALMINOCYCLINE HYDROCHLORIDE · 1991-12-30
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.